DATA SOVEREIGNTY STATEMENT & BIOLOGICAL IP NOTICE
==========================================================
AUTHOR/SUBJECT: [Your Name or Researcher ID]
JURISDICTION: Gauteng, South Africa
DATE: January 11, 2026
REF: COVID-19 Survival Case Study / NDE Observation Papers

1. DECLARATION OF SOVEREIGNTY:
The author asserts full ownership of all genomic, proteomic, and clinical 
data referenced in the attached research. This data is derived from 
the author's unique biological adaptation and independent documentation 
of a Critical Non-ICU survival event.

2. ACCESS & RETURN OF RESULTS (POPIA Section 23):
- The author mandates the "Return of Results." Any institution sequencing 
  this sample must provide the author with a complete copy of the Raw 
  Genomic Data (specifically .vcf or FASTQ files).
- The author retains the right to "Data Portability," allowing for the 
  transfer of this code to independent decentralized vaults.

3. RESTRICTIONS ON FURTHER PROCESSING (POPIA Section 15):
- CONSENT IS LIMITED: This data is provided for specific research into 
  viral resistance only. 
- PROHIBITION OF BROAD CONSENT: The author explicitly denies "Broad Consent." 
  Further processing for unrelated studies or third-party commercial 
  gain is strictly prohibited without a secondary Data Participation Agreement.
- NO PATENT WITHOUT DIVIDEND: Any Intellectual Property (IP) or drug 
  discovery derived from this data is subject to a "Patient Dividend" 
  royalty model for the author.

4. DE-IDENTIFICATION & RE-IDENTIFICATION:
The author acknowledges the technical risk of re-identification. Any 
unauthorized attempt to re-identify the author's anonymized data 
will be treated as a violation of the South African Constitution 
and the Protection of Personal Information Act.

----------------------------------------------------------
"I am because we are. My data, my sovereignty."
----------------------------------------------------------
